These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 24446259)
1. HPLC-MS/MS method for quantitative determination of the novel dual inhibitor of FGF and VEGF receptors E-3810 in tumor tissues from xenograft mice and human biopsies. Zangarini M; Ceriani L; Bello E; Damia G; Cereda R; Camboni MG; Zucchetti M J Mass Spectrom; 2014 Jan; 49(1):19-26. PubMed ID: 24446259 [TBL] [Abstract][Full Text] [Related]
2. Application of a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method to the pharmacokinetics, tissue distribution and excretion studies of felotaxel (SHR110008) in tumor-bearing mice. Ding Y; Lu C; Yang J; Jin X; Yang L; Wang C; Ma Z; Zhu Y; Ding L; Jia Y; Wen A J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Mar; 887-888():61-6. PubMed ID: 22309773 [TBL] [Abstract][Full Text] [Related]
3. E-3810 is a potent dual inhibitor of VEGFR and FGFR that exerts antitumor activity in multiple preclinical models. Bello E; Colella G; Scarlato V; Oliva P; Berndt A; Valbusa G; Serra SC; D'Incalci M; Cavalletti E; Giavazzi R; Damia G; Camboni G Cancer Res; 2011 Feb; 71(4):1396-405. PubMed ID: 21212416 [TBL] [Abstract][Full Text] [Related]
4. Comparative study of A HPLC-MS assay versus an UHPLC-MS/MS for anti-tumoral alkyl lysophospholipid edelfosine determination in both biological samples and in lipid nanoparticulate systems. Estella-Hermoso de Mendoza A; Campanero MA; Mollinedo F; Blanco-Príeto MJ J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Dec; 877(31):4035-41. PubMed ID: 19896423 [TBL] [Abstract][Full Text] [Related]
5. Quantitative analysis of PD 0332991 in xenograft mouse tumor tissue by a 96-well supported liquid extraction format and liquid chromatography/mass spectrometry. Nguyen L; Zhong WZ; Painter CL; Zhang C; Rahavendran SV; Shen Z J Pharm Biomed Anal; 2010 Nov; 53(3):228-34. PubMed ID: 20236782 [TBL] [Abstract][Full Text] [Related]
6. A validated high-performance liquid chromatography-tandem mass spectrometry method for quantification of gefitinib and its main metabolites in xenograft mouse tumor: Application to a pharmacokinetics study. Zhao C; Zheng N; Yang F; Han SY; Li PP Biomed Chromatogr; 2019 Nov; 33(11):e4638. PubMed ID: 31261446 [TBL] [Abstract][Full Text] [Related]
7. Development and validation of an high performance liquid chromatography-tandem mass spectrometry method for the determination of imatinib in rat tissues. Bianchi F; Caffarri E; Cavalli S; Lagrasta C; Musci M; Quaini F; Savi M J Pharm Biomed Anal; 2013 Jan; 73():103-7. PubMed ID: 22709608 [TBL] [Abstract][Full Text] [Related]
8. Specific method for determination of gefitinib in human plasma, mouse plasma and tissues using high performance liquid chromatography coupled to tandem mass spectrometry. Zhao M; Hartke C; Jimeno A; Li J; He P; Zabelina Y; Hidalgo M; Baker SD J Chromatogr B Analyt Technol Biomed Life Sci; 2005 May; 819(1):73-80. PubMed ID: 15797523 [TBL] [Abstract][Full Text] [Related]
9. Development and validation of a high-performance liquid chromatography-tandem mass spectrometry method for the determination of the novel inhibitor of angiogenesis E-3810 in human plasma and its application in a clinical pharmacokinetic study. Sala F; Bagnati R; Livi V; Cereda R; D'Incalci M; Zucchetti M J Mass Spectrom; 2011 Oct; 46(10):1039-45. PubMed ID: 22012670 [TBL] [Abstract][Full Text] [Related]
10. Development and validation of a liquid chromatography-tandem mass spectrometry method for the determination of ST1926, a novel oral antitumor agent, adamantyl retinoid derivative, in plasma of patients in a Phase I study. Sala F; Zucchetti M; Bagnati R; D'Incalci M; Pace S; Capocasa F; Marangon E J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):3118-26. PubMed ID: 19695967 [TBL] [Abstract][Full Text] [Related]
11. A highly sensitive and selective method for the determination of leukotriene B4 (LTB4) in ex vivo stimulated human plasma by ultra fast liquid chromatography-tandem mass spectrometry. Lin W; Huang MQ; Xue X; Bertelsen K; Chen G; Zhao H; Lin ZJ; Fourie A; de Jong J; Weng N J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Apr; 925():54-62. PubMed ID: 23523878 [TBL] [Abstract][Full Text] [Related]
12. Development and validation of ultra high performance liquid chromatography-mass spectrometry method for LBH589 in mouse plasma and tissues. Estella-Hermoso de Mendoza A; Imbuluzqueta I; Campanero MA; Gonzalez D; Vilas-Zornoza A; Agirre X; Lana H; Abizanda G; Prosper F; Blanco-Prieto MJ J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Nov; 879(30):3490-6. PubMed ID: 21983199 [TBL] [Abstract][Full Text] [Related]
13. Development and validation of a rapid LC-MS/MS method for the determination of JCC76, a novel antitumor agent for breast cancer, in rat plasma and its application to a pharmacokinetics study. Cai X; Zhong B; Su B; Xu S; Guo B Biomed Chromatogr; 2012 Sep; 26(9):1118-24. PubMed ID: 22213194 [TBL] [Abstract][Full Text] [Related]
14. Sensitive liquid chromatography/tandem mass spectrometry method for the determination of the lipophilic antipsychotic drug chlorpromazine in rat plasma and brain tissue. Zhang G; Terry AV; Bartlett MG J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jul; 854(1-2):68-76. PubMed ID: 17452027 [TBL] [Abstract][Full Text] [Related]
15. Anti-vascular endothelial growth factor receptor-1 antagonist antibody as a therapeutic agent for cancer. Wu Y; Zhong Z; Huber J; Bassi R; Finnerty B; Corcoran E; Li H; Navarro E; Balderes P; Jimenez X; Koo H; Mangalampalli VR; Ludwig DL; Tonra JR; Hicklin DJ Clin Cancer Res; 2006 Nov; 12(21):6573-84. PubMed ID: 17085673 [TBL] [Abstract][Full Text] [Related]
16. HPLC-MS/MS method to measure trabectedin in tumors: preliminary PK study in a mesothelioma xenograft model. Ceriani L; Ferrari M; Zangarini M; Licandro SA; Bello E; Frapolli R; Falcetta F; D'Incalci M; Libener R; Grosso F; Aviles P; Zucchetti M Bioanalysis; 2015; 7(15):1831-42. PubMed ID: 26295985 [TBL] [Abstract][Full Text] [Related]
17. Development and validation of a highly rapid and sensitive LC-MS/MS method for determination of SZ-685C, an investigational marine anticancer agent, in rat plasma--application to a pharmacokinetic study in rats. Chen JY; Wang XD; Zhong GP; Qin XL; Li JL; Huang ZY; Zhu X; Li MF; Huang M J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jul; 879(22):2127-34. PubMed ID: 21703949 [TBL] [Abstract][Full Text] [Related]
18. High-performance liquid chromatography analysis of a novel small-molecule, anti-cancer drug, Palomid 529, in human and mouse plasma and in mouse tissue homogenates. Lin F; Sherris D; Beijnen JH; Van Tellingen O J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Dec; 879(32):3823-31. PubMed ID: 22100549 [TBL] [Abstract][Full Text] [Related]
19. Determination of chemically reduced pyrrolobenzodiazepine SJG-136 in human plasma by HPLC-MS/MS: application to an anticancer phase I dose escalation study. Wade Calcutt M; Lee W; Puzanov I; Rothenberg ML; Hachey DL J Mass Spectrom; 2008 Jan; 43(1):42-52. PubMed ID: 17683023 [TBL] [Abstract][Full Text] [Related]
20. Determination of unbound vismodegib (GDC-0449) concentration in human plasma using rapid equilibrium dialysis followed by solid phase extraction and high-performance liquid chromatography coupled to mass spectrometry. Deng Y; Wong H; Graham RA; Liu W; Shen HS; Shi Y; Wang L; Meng M; Malhi V; Ding X; Dean B J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jul; 879(22):2119-26. PubMed ID: 21704573 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]